61 results on '"DeCensi, A."'
Search Results
2. Estimating the magnitude of clinical benefit of systemic therapy in patients with DCIS or pre-invasive disease of the breast
3. PIK3CA Mutation, Aspirin Use after Diagnosis and Survival of Colorectal Cancer. A Systematic Review and Meta-analysis of Epidemiological Studies
4. Worry and risk perception of breast cancer in a prevention trial of low dose tamoxifen in midlife postmenopausal hormone users
5. Adjuvant therapy in patients with ductal carcinoma in situ of the breast: The Pandora’s box
6. The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast
7. Health-related quality of life in women with recurrent ovarian cancer receiving paclitaxel plus trebananib or placebo (TRINOVA-1)
8. Long-term effects of inhaled budesonide on screening-detected lung nodules
9. Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer
10. Association of molecular subtypes with Ki-67 changes in untreated breast cancer patients undergoing pre-surgical trials
11. A phase-III prevention trial of low-dose tamoxifen in postmenopausal hormone replacement therapy users: the HOT study
12. Effect of low-dose tamoxifen after surgical excision of ductal intraepithelial neoplasia: results of a large retrospective monoinstitutional cohort study
13. Exemestane: One part of the chemopreventive spectrum for ER-positive breast cancer
14. Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancer
15. The science behind vitamins and natural compounds for breast cancer prevention. Getting the most prevention out of it
16. Low-dose tamoxifen in the treatment of breast ductal intraepithelial neoplasia: results of a large observational study
17. The rationale and potential of cancer chemoprevention with special emphasis on breast cancer
18. Computer-assisted image analysis of breast fine needle aspiration in a randomized chemoprevention trial of fenretinide vs. placebo in HRT users
19. Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer
20. SERMs in chemoprevention of breast cancer
21. Pharmacological prevention of breast cancer: Quo Vadis?
22. Recent advances in cancer chemoprevention, with emphasis on breast and colorectal cancer
23. Effect of tamoxifen on lipoprotein(a) and insulin-like growth factor-I (IGF-I) in healthy women
24. LBA58 - BAROCCO: A randomized phase II study of weekly paclitaxel vs cediranib-olaparib combination given with continuous or intermittent schedule in patients with recurrent platinum resistant ovarian cancer (PROC)
25. 114P - Molecular imaging with 18F-fluoroestradiol (18F-FES) to assess intra-patient heterogeneity in metastatic breast cancer (MBC): A European TRANSCAN program
26. 862P - Hormonal therapy for epithelial ovarian cancer: a systematic review and meta-analysis of phase II studies
27. 204P - Dual block versus single agent trastuzumab plus chemotherapy as neoadjuvant treatment of HER2-positive breast cancer: a meta-analysis of randomized trials
28. N06 - The role of factors affecting worry and risk perception of breast cancer in a chemoprevention trial of tamoxifen
29. Inflammation and cancer prevention
30. BP129 INSULIN RESISTANCE (IR) AND PROGNOSIS OF METASTATIC BREAST CANCER (MBC) PATIENTS
31. E01* - PIK3CA mutation, aspirin use after diagnosis and survival of colorectal cancer. A systematic review and meta-analysis of epidemiological studies
32. 2702 Safety and efficacy in ROSiA, a single-arm study of extended duration front-line (FL) bevacizumab (BEV)-containing therapy in 1021 women with ovarian cancer (OC)
33. 327PD - Body Mass Index and Prognosis of Women With Metastatic Breast Cancer
34. P1 Circulating adiponectin levels as a predictive factor of breast cancer in a double-blind 2×2 phase II trial of low-dose tamoxifen and fenretinide for breast cancer prevention
35. S21 Chemoprevention of breast cancer: The Italian experience with retinoids and low-dose tamoxifen
36. S10 Chemoprevention of breast cancer for mutation carriers and other high risk women
37. Strategies to optimize tamoxifen use
38. 2 Pitfalls in developing cancer chemoprevention agents
39. P41 A randomized 2 × 2 biomarker trial of low-dose tamoxifen and fenretinide in premenopausal women at-high risk for breast cancer
40. P40 The HOT study: Hormone replacement therapy opposed by low dose of tamoxifen. A phase III trial of breast cancer prevention with low dose tamoxifen in HRT users: Background and rationale of the project
41. Session 6 Primary prevention of breast cancer II: Update of chemoprevention with tamoxifen, raloxifen and aromatase-inhibitors: S16. Is low-dose tamoxifen a reasonable alternative?
42. Endocrine environment and breast cancer risk
43. Distribution of tamoxifen in serum and breast cancer tissue and its effects on sex hormone-binding globulin (SHBG)
44. Pharmacological prevention of breast cancer: Quo vadis?
45. Session 5 S16. HRT opposed by tamoxifen (HOT study): Rationale and design
46. Rationale for a study adding tamoxifen to HRT
47. Update on tamoxifen to prevent breast cancer. The Italian Tamoxifen Prevention Study
48. Correlation between plasma transforming growth factor-β1 and second primary breast cancer in a chemoprevention trial
49. Socioeconomic status and survival of gastric cancer patients
50. Goserelin acetate with or without flutamide in the treatment of patients with locally advanced or metastatic prostate cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.